Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 23, 2016
ADVISORY, March 23, 2016 (GLOBE NEWSWIRE) -- What: LabStyle Innovations Corp. (Nasdaq:DRIO), developer of the Dario™ Blood Glucose Monitoring System, will visit the Nasdaq MarketSite in Times...
-
Mar 15, 2016World's largest glucose monitoring market gets user-centric mHealth product that brings diabetes management into the digital age
LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, announced today the national availability of Dario in the U.S. The U.S. rollout follows the...
-
Mar 9, 2016Broadens platform technology's applications beyond mHealth and into health and non-health related industrial markets
LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, announced today the U.S. Patent and Trademark Office has issued the Company patent #9257038...
-
Mar 4, 2016Company Effects a 1-for-18 Reverse Stock Split
LabStyle Innovations Corp. (DRIO), developer of the Dario™ Diabetes Management Solution, today announced approval to list its common stock and warrants on the NASDAQ Capital Market effective...
-
Feb 9, 2016- FDA clearance announced on December 22nd
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, reported financial and operational results for the year ended December 31, 2015 and provided an...
-
Jan 26, 2016- Sales channels to include direct-to-consumer, e-commerce, third-party distributors
CAESAREA, Israel / LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Blood Glucose Monitoring System, today announced it is preparing to launch its FDA-cleared product in the...
-
Dec 22, 2015Smartphone-based blood glucose monitor with unique all-in-one design cleared for launch in the world's largest diabetes market
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced that the United States Food and Drug Administration (FDA) has granted 510(k)...
-
Dec 16, 2015
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced its personalized smart blood glucose meter has recently been featured in numerous...
-
Nov 19, 2015A LabStyle distributor participated in the investment
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced it has closed on an offering raising approximately $2.3 million in proceeds...
-
Nov 16, 2015Mobile healthcare apps and social media become platform for user-centric revolution enabling people to take charge of their health
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced that Facebook (NASDAQ:FB) published a case study about the Company's social media...
-
Nov 13, 2015- 56% increase in sequential quarterly revenues
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today reported financial and operational results for the three months ended September 30, 2015 and...
-
Nov 11, 2015Centaur, one of India's leading healthcare companies, to offer Dario in a region where over 66 million people live with diabetes
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, announced today that it has signed an exclusive distribution agreement with one of India's leading...
-
Oct 29, 2015LabStyle Innovations Reports Dario Blood Glucose Monitor Demonstrates Over 99% Accuracy in New StudyReported in poster presentation at Diabetes Technology Meeting on October 22 and 23, 2015
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced results from a recent performance accuracy study of the Dario™ Blood Glucose...
-
Oct 15, 2015
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced Dr. Paul Rosman, who serves on the Company's Scientific Advisory Board, will...
-
Oct 12, 2015
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced its Medical Director, Dr. Moshe Kamar, will present a patient case study at...
-
Sep 30, 2015Todd Durniak to demonstrate the Dario solution during the breakout session "The Measured Life: Tracking from Head to Toe"
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced that its Executive Vice President of U.S. Operations, Todd Durniak, will deliver a...
-
Sep 17, 2015Medical and tech industry publications interview Exec V.P. of U.S. Operations, Todd Durniak
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced the Dario has recently been featured in numerous U.S.-based media outlets...
-
Sep 9, 2015Mobile health technology market projected to reach $8 billion by 2018
LabStyle Innovations Corp. (OTCQB: DRIO), today announced it has been granted a patent from the U.S. Patent and Trademark Office for U.S. Patent No. 9,125,549 on September 8, 2015. The patent...
-
Sep 3, 2015
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced the Company will present at the Rodman & Renshaw 17th Annual Global Investment...
-
Aug 31, 2015Investors include company officers, employees, friends & family; Participating high net worth private investors include current shareholders and a new investment by Shmuel Farhi
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced it recently closed a round of funding totaling approximately $2.5 million. Funds...
-
Aug 25, 2015Dario Diabetes Management Solution is very well received in Australian market following recent regulatory and reimbursement approvals
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced that in conjunction with its Australian distributor, uHealth, the Company is...
-
Aug 13, 2015-- 161% jump in sequential quarterly revenues
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today reported financial and operational results for the three-month period ended June 30, 2015,...
-
Jul 29, 2015Benefits of the recently launched Dario highlighted nationwide to Australian viewers
LabStyle Innovations Corp. (DRIO), today announced that its Dario™ Diabetes Management Solution was featured in a national broadcast news segment in Australia. The Dario was recently launched in...
-
Jul 22, 2015Q&A with Managing Editor includes in-depth interview about LabStyle's leadership in the diabetes and digital health industries
LabStyle Innovations Corp. (DRIO), today announced that its President & CEO Erez Raphael is featured on the cover of the July 21issue of Opportunist Magazine. In the feature article Raphael talks...
-
Jul 14, 2015Insurance claims for the Dario Test Strips to be reimbursed in Canada
LabStyle Innovations Corp. (DRIO), today announced the Dario™ Diabetes Management Solution's Smart Meter test strips are now reimbursed in Canada by most private insurance plans after the...